Detalhe da pesquisa
1.
Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema.
N Engl J Med
; 379(4): 352-362, 2018 07 26.
Artigo
Inglês
| MEDLINE | ID: mdl-30044938
2.
Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial.
J Transl Med
; 15(1): 2, 2017 01 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28049490
3.
Anti-GPVI Fab SAR264565 effectively blocks GPVI function in ex vivo human platelets under arterial shear in a perfusion chamber.
Eur J Clin Pharmacol
; 73(8): 949-956, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28523478
4.
Pharmacokinetic Analysis of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium in Calcineurin Inhibitor-Free Renal Transplant Recipients.
Ther Drug Monit
; 38(3): 388-92, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26829599
5.
Novel oral anticoagulants: clinical pharmacology, indications and practical considerations.
Eur J Clin Pharmacol
; 69(9): 1617-33, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23619611
6.
Platelet activation markers after conversion from azathioprine to sirolimus based immunosuppression in renal transplant recipients.
Int J Clin Pharmacol Ther
; 50(12): 873-9, 2012 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-23006444
7.
Prophylaxis of hereditary angioedema attacks: A randomized trial of oral plasma kallikrein inhibition with avoralstat.
J Allergy Clin Immunol
; 138(3): 934-936.e5, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27302552
8.
Significant effects of tipranavir on platelet aggregation and thromboxane B2 formation in vitro and in vivo.
J Antimicrob Chemother
; 61(2): 394-9, 2008 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-18156609
9.
Platelet-leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors.
J Antimicrob Chemother
; 62(5): 1118-21, 2008 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-18753189
10.
Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity.
J Clin Pharmacol
; 47(11): 1398-407, 2007 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-17873238
11.
Effects of parecoxib and dipyrone on platelet aggregation in patients undergoing meniscectomy: a double-blind, randomized, parallel-group study.
Clin Ther
; 29(3): 438-47, 2007 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-17577465
12.
Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
Clin Pharmacol Ther
; 78(5): 468-76, 2005 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-16321613
13.
Induction of central signalling pathways and select functional effects in human platelets by beta-boswellic acid.
Br J Pharmacol
; 146(4): 514-24, 2005 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-16086030
14.
Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P-selectin expression in a human ex vivo in vitro model.
Clin Pharmacol Ther
; 71(3): 176-85, 2002 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-11907492
15.
Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
Clin Pharmacol Ther
; 73(3): 232-41, 2003 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-12621388
16.
Immunosuppressive therapy regimen and platelet activation in renal transplant patients.
Clin Pharmacol Ther
; 72(4): 411-8, 2002 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-12386643
17.
Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effects on prothrombin time, activated partial thromboplastin time, and Ecarin Clotting Time.
Thromb Haemost
; 91(6): 1137-45, 2004 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-15175800
18.
Pharmacodynamic profile of antiplatelet agents: marked differences between single versus costimulation with platelet activators.
Thromb Res
; 113(5): 295-302, 2004.
Artigo
Inglês
| MEDLINE | ID: mdl-15183041
19.
Anticoagulant therapy with the oral direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban and the thrombin inhibitor dabigatran etexilate in patients with hepatic impairment.
Clin Pharmacokinet
; 52(4): 243-54, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23389892
20.
Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.
Pharmacogenet Genomics
; 19(6): 407-14, 2009 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-19373123